Table 2 Stages of rising heat for different items in China’s COVID-19 research and release dates of relevant policies and guidelines
Item | Stage of rising heat | Relevant policies or guidelines in the early stage | Relevant policies or guidelines in the late stage | ||
|---|---|---|---|---|---|
Name | Release date | Name | Release date | ||
Chloroquine | 2.17–2.27 | Diagnosis and Treatment Protocol of COVID-19 (Trial Version 6) | 2.19 | Notice on Adjusting the Usage and Dosage of Chloroquine Phosphate in Treating COVID-19 on a Trial Basis | 2.28 |
Mask | 2.17–3.18 | Notice on Issuing the Technical Guidelines on the Selection and Use of Masks Used for Prevention and Control of COVID-19 in Different Populations | 2.05 | Notice on Issuing the Guidelines on the Scientific Wearing of Masks | 3.18 |
Infectious disease transmission, patient-to-professional | 3.18–4.17 | Notice on Further Strengthening Protection of Medical Staff during COVID-19 Prevention and Control | 2.19 | Notice on Further Strengthening Infection Prevention and Control at Medical Institutions during COVID-19 | 3.13 |
Telemedicine | 2.17–2.27 | Notice on Effectively Conducting Internet-Based Diagnosis, Treatment, and Consultation Service Work during COVID-19 Prevention and Control | 2.07 | Notice on Conducting Online Services to Further Strengthen COVID-19 Prevention and Control Work in Hubei Province | 2.26 |
Patient discharge | 2.27–3.08 | Diagnosis and Treatment Protocol of COVID-19 (Trial Version 6) | 2.19 | Diagnosis and Treatment Protocol of COVID-19 (Trial Version 7) | 3.04 |